Stericycle (NASDAQ:SRCL) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Stericycle (NASDAQ:SRCL) posted its earnings results on Thursday. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.03, Briefing.com reports. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The firm had revenue of $664.90 million during the quarter, compared to analysts’ expectations of $676.42 million. During the same period in the previous year, the business posted $0.49 EPS. The business’s revenue was down 2.8% compared to the same quarter last year. Stericycle updated its FY 2024 guidance to 2.200-2.500 EPS.

Stericycle Stock Performance

Shares of SRCL stock opened at $46.31 on Friday. The company has a quick ratio of 0.94, a current ratio of 1.11 and a debt-to-equity ratio of 0.55. The company has a 50-day moving average of $51.35 and a two-hundred day moving average of $48.20. Stericycle has a 1-year low of $37.78 and a 1-year high of $57.06.

Analyst Ratings Changes

Several research firms recently issued reports on SRCL. Royal Bank of Canada reiterated an “outperform” rating and issued a $69.00 target price on shares of Stericycle in a research note on Thursday, March 7th. Truist Financial upped their price objective on shares of Stericycle from $50.00 to $57.00 and gave the stock a “hold” rating in a research report on Thursday, February 29th. Wells Fargo & Company upped their price objective on shares of Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a research report on Friday, March 1st. Stifel Nicolaus upped their price objective on shares of Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a research report on Thursday, February 29th. Finally, StockNews.com lowered shares of Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $60.80.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.